Pathogenic Bacteria and Fungi: Virulence, Antimicrobial Resistance, and Modern Strategies for Diagnosis and Control (2020–2026)
DOI:
https://doi.org/10.55892/jrg.v9i20.2844Keywords:
Antimicrobial resistance, Microbial virulence, Biofilms, Pathogenic fungiAbstract
Pathogenic bacteria and fungi represent structural challenges to global health and food security, driven by increasing antimicrobial resistance and the complexity of their virulence mechanisms. This narrative review analyzes the emergence of these agents under the One Health perspective, detailing biological strategies such as biofilm formation, phenotypic plasticity, and horizontal gene transfer that sustain persistence in clinical and productive environments. The critical impact of priority pathogens (such as Candida auris and multidrug-resistant bacteria) and therapeutic scarcity, especially antifungal, aggravated by environmental selective pressure, are discussed. The study also evaluates diagnostic advances, highlighting metagenomics (mNGS) and genomic surveillance as decisive tools for traceability and outbreak control. It is concluded that mitigating these threats depends on the integration of technological innovation, rapid diagnostics, and robust health governance, essential to preserve therapeutic efficacy and the sustainability of health systems.
Downloads
References
BURKI, T. K. Fungal priority pathogens list. The Lancet Microbe, DOI: 10.1016/S2666-5247(23)00003-4.2023
CASADEVALL, A. Host-pathogen interactions and the pathogenesis of infectious diseases: a perspective. Virulence. DOI: 10.1080/21505594.2025.2547090. 2025
CHEUNG, G. Y. C.; BAE, J. S.; OTTO, M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. DOI: 10.1080/21505594.2021.1878688.2021
CHOWDHARY, A. et al. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. Nature Reviews Microbiology. DOI: 10.1038/s41579-021-00538-5. 2021
CIUREA, C. N. et al. Candida and candidiasis—opportunism, pathogenicity, host immune response, and microbiota. Microorganisms,. DOI: 10.3390/microorganisms8060857. 2020
CORTEGIANI, A. et al. Candida auris: epidemiology, clinical characteristics, resistance, and management. The Lancet Microbe. DOI: 10.1016/S2666-5247(23)00114-3. 2023
FISHER, M. C. et al. Threats posed by the fungal kingdom to humans, wildlife, and agriculture. mBio. DOI: 10.1128/mBio.00449-20. 2020
FISHER, M. C.; DENNING, D. W. The worldwide priority of fungal pathogens. Nature Reviews Microbiology. DOI: 10.1038/s41579-023-00861-x. 2023
GARNICA, M. et al. Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia. The Brazilian Journal of Infectious Diseases. DOI: 10.1016/j.bjid.2021.101548. 2021
MURRAY, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. DOI: 10.1016/S0140-6736(21)02724-0. 2022
MURRAY, C. J. L. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis. The Lancet. DOI: 10.1016/S0140-6736(24)01867-1. 2024
NOURI, R. et al. CRISPR-based detection of infectious diseases: a review. Nature Biomedical Engineering. DOI: 10.1038/s41551-021-00760-7. 2021
POIREL, L. et al. Plasmid-mediated colistin resistance genes: mcr. Trends in Microbiology. DOI: 10.1016/j.tim.2023.10.006. 2024
QIN, S. et al. Emerging understanding of Pseudomonas aeruginosa pathogenesis and virulence factors. Signal Transduction and Targeted Therapy. DOI: 10.1038/s41392-022-01056-1. 2022
RODRÍGUEZ-CERDEIRA, C. et al. Candida infections: an update on epidemiology, pathogenesis, diagnosis and treatment. Frontiers in Microbiology. DOI: 10.3389/fmicb.2020.544480. 2020
RODRIGUES, M. E. et al. Fungal biofilms and polymicrobial disease. Journal of Fungi,. DOI: 10.3390/jof7080603. 2021
SACHDEVA, S. et al. Metabolic allies or adversaries: bacterial and fungal interactions shaping pathogenicity. Critical Reviews in Microbiology,. DOI: 10.1080/1040841X.2024.2397359. 2024
SATALA, D. et al. Antifungal resistance in biofilm-associated infections. Frontiers in Cellular and Infection Microbiology. DOI: 10.3389/fcimb.2021.765942. 2022
SCHIMMER, J. et al. Clinical metagenomic sequencing for pathogen detection: applications and considerations. Frontiers in Cellular and Infection Microbiology. DOI: 10.3389/fcimb.2024.1458316. 2024
THORPE, H. A. et al. Deep sequencing for infection prevention and control in healthcare. The Lancet Microbe. DOI: 10.1016/S2666-5247(24)00113-7. 2024
UDDIN, T. M. et al. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. Journal of Infection and Public Health. DOI: 10.1016/j.jiph.2021.10.020. 2021
VERWEIJ, P. E. et al. Azole resistance in Aspergillus fumigatus: a global public health issue. mBio. DOI: 10.1128/mbio.01871-20. 2021
WORLD HEALTH ORGANIZATION. WHO bacterial priority pathogens list: 2024 update. The Lancet Infectious Diseases. DOI: 10.1016/S1473-3099(25)00118-5. 2025





































